Number of Clinical Trials 2021
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #143
Sierra Leone
- #142
Niger
- #141
Myanmar
- #140
Monaco
- #139
Martinique
- #138
Guatemala
- #137
Guadeloupe
- #136
Gambia
- #135
Eswatini
- #134
El Salvador
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Czech Republic
The Czech Republic ranked #34 globally with a total of 69 clinical trials in 2021. This figure is notable compared to neighboring countries, as it reflects a growing interest in clinical research within Central Europe. Contributing factors include the country's robust healthcare infrastructure, a well-educated workforce, and favorable regulatory conditions that attract international pharmaceutical companies.
Honduras
In 2021, Honduras ranked #114 globally with a total of 2 clinical trials. This number is significantly lower than many of its Central American neighbors, reflecting challenges in attracting international research investment. Factors such as limited healthcare infrastructure, economic constraints, and a relatively small population contribute to the low number of clinical trials conducted in the country.
Finland
In 2021, Finland ranked #37 globally with a total of 63 clinical trials. This figure is notably lower than the global leader, the United States, which conducts thousands of trials annually. Finland's robust healthcare system, combined with its commitment to research and innovation, fosters a conducive environment for clinical studies, although its smaller population compared to larger countries may limit the number of trials conducted.
Georgia
In 2021, Georgia ranked #83 globally with a total of 6 clinical trials. This number is lower than many of its regional peers, indicating a relatively modest presence in the clinical research landscape compared to top-ranked countries. Factors contributing to this statistic include Georgia's developing healthcare infrastructure and its strategic positioning as a gateway between Europe and Asia, which presents both opportunities and challenges for attracting clinical research investments.
Romania
In 2021, Romania ranked #50 globally with a total of 31 clinical trials. This number is relatively low compared to higher-ranking countries, reflecting challenges in attracting international research investments. Romania's strategic location in Eastern Europe, along with a growing healthcare sector and a young population, contributes to its potential for increased clinical trial activity in the future.
Estonia
In 2021, Estonia ranked #99 globally with a total of 3 clinical trials. This figure is notably lower than the global average, indicating limited activity in clinical research compared to leading countries. Factors contributing to this low number include Estonia's small population and a relatively nascent research infrastructure, which may hinder the scale and scope of clinical studies.
Cameroon
In 2021, Cameroon ranked #72 globally with a total of 10 clinical trials. This number is relatively low compared to regional leaders, indicating a need for improvement in clinical research infrastructure. Contributing factors include limited funding for healthcare research and a growing demand for better healthcare solutions in a country with a diverse population and various health challenges.
Chile
In 2021, Chile ranked #48 globally with 32 clinical trials. This figure is relatively modest compared to leading countries in clinical research, reflecting a growing but still developing research infrastructure in the region. Key drivers for clinical trials in Chile include its stable healthcare system and increasing investment in biomedical research, which attract both local and international sponsors.
Algeria
In 2021, Algeria ranked #91 globally with a total of 4 clinical trials. This figure is notably lower than many neighboring countries, reflecting a significant gap in research activity in the region. Contributing factors include limited investment in healthcare research and development, as well as regulatory challenges that hinder the growth of clinical research infrastructure.
Ghana
In 2021, Ghana ranked #94 globally with a total of 4 clinical trials. This number is notably lower than the regional average in West Africa, where countries like Nigeria lead with a significantly higher count. Factors contributing to Ghana's limited clinical trial activity include a smaller pharmaceutical sector and challenges in research funding, which can hinder the growth of clinical research initiatives.
Analysis & Context
In 2021, the United States led the world in the Number of Clinical Trials with an impressive total of 6136, while the global range spanned from just 1 in several countries to this maximum. The average number of clinical trials conducted across the 143 reported countries was 134.52, with a median value of 10.00, highlighting a significant disparity in global research activity.
Global Leaders in Clinical Trials
The dominance of the United States in clinical trials is attributed to its robust healthcare infrastructure, extensive pharmaceutical industry, and strong regulatory framework, which collectively facilitate a high volume of research. Other top-performing countries include France with 1387 trials and Turkey with 1261. France's position is bolstered by its advanced healthcare system and collaborative research environment, while Turkey's significant output can be linked to its strategic initiatives to boost pharmaceutical research and development.
Meanwhile, China, with 1164 trials, benefits from substantial government investment in medical research and a large population base, providing a vast pool of clinical trial participants. Egypt also stands out with 858 trials, reflecting its emerging role as a hub for clinical research in the Middle East and North Africa due to strategic location and improving healthcare facilities.
Challenges in Low-Performing Countries
At the other end of the spectrum, several countries reported conducting only 1 clinical trial in 2021, including Niger, Costa Rica, and Congo. These low numbers often result from limited healthcare infrastructure, insufficient funding for research, and regulatory challenges. For instance, many African nations face barriers such as a lack of trained personnel and inadequate research facilities, which hinder the development and execution of clinical trials.
The minimal trial activity in these countries highlights a critical need for international collaboration and investment to enhance research capabilities and address global health disparities.
Year-over-Year Changes in Clinical Trial Activity
The year 2021 saw notable changes in clinical trial numbers across various countries. China experienced the largest increase, adding 197 trials (a 20.4% rise), driven by its continued emphasis on innovation and biotechnology. Similarly, Turkey and France saw increases of 149 and 103 trials, respectively, reflecting sustained investment in medical research.
Conversely, the United States saw a decrease of 84 trials, perhaps due to the ongoing impacts of the COVID-19 pandemic, which shifted research priorities and resources. Other countries with significant decreases include Brazil and Germany, with reductions of 41 and 35 trials, respectively. These declines may reflect economic pressures and logistical challenges exacerbated by the pandemic.
Implications for Global Health Research
The disparities in the Number of Clinical Trials conducted across countries have profound implications for global health research. Countries with high trial numbers, like the United States and France, are better positioned to advance medical innovations and respond to health crises swiftly. In contrast, nations with fewer trials risk falling behind in medical advancements and may have limited access to new therapies.
Addressing these imbalances requires targeted international support to build research capacities in underperforming regions. Collaborative efforts, such as funding partnerships and training programs, can play a pivotal role in enhancing global health outcomes and ensuring equitable access to medical advancements.
Frequently Asked Questions About Number of Clinical Trials in 2021
Which country conducted the most clinical trials in 2021?
The United States conducted the most clinical trials in 2021, with a total of 6,136 trials.
Which country conducted the fewest clinical trials in 2021?
Niger conducted the fewest clinical trials in 2021, with only 1 trial.
What is the average number of clinical trials conducted per country in 2021?
The average number of clinical trials conducted per country in 2021 was 135.
What is the median number of clinical trials conducted per country in 2021?
The median number of clinical trials conducted per country in 2021 was 10.
Which countries are in the top 3 for the number of clinical trials conducted in 2021?
The top 3 countries for the number of clinical trials conducted in 2021 are the United States with 6,136 trials, France with 1,387 trials, and Turkey with 1,261 trials.
How many countries conducted only 1 clinical trial in 2021?
Ten countries conducted only 1 clinical trial in 2021, including Niger, Costa Rica, and Congo.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2021. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2021
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.